Reports - Plasma Therapy Market
HealthcarePlasma Therapy Market
Plasma Therapy Market Valuation and Future Projections to 2035 by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin, Hyperbaric Oxygen Therapy (HBOT), Combined Plasma Therapy with Stem Cells, Other Types) by Source (Autologous, Allogenic) by Application (Orthopedics, Dermatology, Hematology, Neurology, Immunology, Dental, Other Applications) by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa, Latin America
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Plasma Therapy Market - Segment Analysis
1. Overview
2. Global Plasma Therapy Market, 2021 - 2035 (USD Million)
3. Global Plasma Therapy Market - by Type
3.1. By Pure PRP
3.2. By Leukocyte-Rich PRP
3.3. By Pure Platelet-Rich Fibrin
3.4. By Leukocyte-Rich Fibrin
3.5. By Hyperbaric Oxygen Therapy (HBOT)
3.6. By Combined Plasma Therapy with Stem Cells
3.7. By Other Types
4. Global Plasma Therapy Market - by Source
4.1. By Autologous
4.2. By Allogenic
5. Global Plasma Therapy Market - by Application
5.1. By Orthopedics
5.2. By Dermatology
5.3. By Hematology
5.4. By Neurology
5.5. By Immunology
5.6. By Dental
5.7. By Other Applications
6. Global Plasma Therapy Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Ambulatory Surgical Centers
6.4. By Research Institutes
6.5. By Other End-Users
7. Global Plasma Therapy Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Plasma Therapy Market - Segment Analysis
1. Overview
2. North America Plasma Therapy Market, 2021 - 2035 (USD Million)
3. North America Plasma Therapy Market - by Type
3.1. By Pure PRP
3.2. By Leukocyte-Rich PRP
3.3. By Pure Platelet-Rich Fibrin
3.4. By Leukocyte-Rich Fibrin
3.5. By Hyperbaric Oxygen Therapy (HBOT)
3.6. By Combined Plasma Therapy with Stem Cells
3.7. By Other Types
4. North America Plasma Therapy Market - by Source
4.1. By Autologous
4.2. By Allogenic
5. North America Plasma Therapy Market - by Application
5.1. By Orthopedics
5.2. By Dermatology
5.3. By Hematology
5.4. By Neurology
5.5. By Immunology
5.6. By Dental
5.7. By Other Applications
6. North America Plasma Therapy Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Ambulatory Surgical Centers
6.4. By Research Institutes
6.5. By Other End-Users
Chapter 5 Europe Plasma Therapy Market - Segment Analysis
1. Overview
2. Europe Plasma Therapy Market, 2021 - 2035 (USD Million)
3. Europe Plasma Therapy Market - by Type
3.1. By Pure PRP
3.2. By Leukocyte-Rich PRP
3.3. By Pure Platelet-Rich Fibrin
3.4. By Leukocyte-Rich Fibrin
3.5. By Hyperbaric Oxygen Therapy (HBOT)
3.6. By Combined Plasma Therapy with Stem Cells
3.7. By Other Types
4. Europe Plasma Therapy Market - by Source
4.1. By Autologous
4.2. By Allogenic
5. Europe Plasma Therapy Market - by Application
5.1. By Orthopedics
5.2. By Dermatology
5.3. By Hematology
5.4. By Neurology
5.5. By Immunology
5.6. By Dental
5.7. By Other Applications
6. Europe Plasma Therapy Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Ambulatory Surgical Centers
6.4. By Research Institutes
6.5. By Other End-Users
Chapter 6 Asia Pacific Plasma Therapy Market - Segment Analysis
1. Overview
2. Asia Pacific Plasma Therapy Market, 2021 - 2035 (USD Million)
3. Asia Pacific Plasma Therapy Market - by Type
3.1. By Pure PRP
3.2. By Leukocyte-Rich PRP
3.3. By Pure Platelet-Rich Fibrin
3.4. By Leukocyte-Rich Fibrin
3.5. By Hyperbaric Oxygen Therapy (HBOT)
3.6. By Combined Plasma Therapy with Stem Cells
3.7. By Other Types
4. Asia Pacific Plasma Therapy Market - by Source
4.1. By Autologous
4.2. By Allogenic
5. Asia Pacific Plasma Therapy Market - by Application
5.1. By Orthopedics
5.2. By Dermatology
5.3. By Hematology
5.4. By Neurology
5.5. By Immunology
5.6. By Dental
5.7. By Other Applications
6. Asia Pacific Plasma Therapy Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Ambulatory Surgical Centers
6.4. By Research Institutes
6.5. By Other End-Users
Chapter 7 Latin America Plasma Therapy Market - Segment Analysis
1. Overview
2. Latin America Plasma Therapy Market, 2021 - 2035 (USD Million)
3. Latin America Plasma Therapy Market - by Type
3.1. By Pure PRP
3.2. By Leukocyte-Rich PRP
3.3. By Pure Platelet-Rich Fibrin
3.4. By Leukocyte-Rich Fibrin
3.5. By Hyperbaric Oxygen Therapy (HBOT)
3.6. By Combined Plasma Therapy with Stem Cells
3.7. By Other Types
4. Latin America Plasma Therapy Market - by Source
4.1. By Autologous
4.2. By Allogenic
5. Latin America Plasma Therapy Market - by Application
5.1. By Orthopedics
5.2. By Dermatology
5.3. By Hematology
5.4. By Neurology
5.5. By Immunology
5.6. By Dental
5.7. By Other Applications
6. Latin America Plasma Therapy Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Ambulatory Surgical Centers
6.4. By Research Institutes
6.5. By Other End-Users
Chapter 8 Middle East & Africa Plasma Therapy Market - Segment Analysis
1. Overview
2. Middle East & Africa Plasma Therapy Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Plasma Therapy Market - by Type
3.1. By Pure PRP
3.2. By Leukocyte-Rich PRP
3.3. By Pure Platelet-Rich Fibrin
3.4. By Leukocyte-Rich Fibrin
3.5. By Hyperbaric Oxygen Therapy (HBOT)
3.6. By Combined Plasma Therapy with Stem Cells
3.7. By Other Types
4. Middle East & Africa Plasma Therapy Market - by Source
4.1. By Autologous
4.2. By Allogenic
5. Middle East & Africa Plasma Therapy Market - by Application
5.1. By Orthopedics
5.2. By Dermatology
5.3. By Hematology
5.4. By Neurology
5.5. By Immunology
5.6. By Dental
5.7. By Other Applications
6. Middle East & Africa Plasma Therapy Market - by End User
6.1. By Hospitals
6.2. By Clinics
6.3. By Ambulatory Surgical Centers
6.4. By Research Institutes
6.5. By Other End-Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Cambryn Biologics LLC (U.S.)
2. BioLife Plasma Services (U.S.)
3. CSL Ltd. (Australia)
4. Biotest Pharmaceuticals (Germany)
5. Kedrion S.P.A. (Italy)
6. Grifols International S.A. (Spain)
7. China Biologic Products Inc. (China)
8. LFB Plasma (U.S.)
9. Octapharma Plasma Inc. (Switzerland)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By